NPPA notified regarding the computation of the retail price of Atorvastatin Calcium IP Equivalent to Atorvastatin 40mg + Clopidogrel Bisulphate IP Equivalent to Clopidogrel IP 75mg for M/s Pure And Cure Healthcare Pvt Limited

Feb 11, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 10, 2025, notified regarding the computation of the retail price of Atorvastatin Calcium IP Equivalent to Atorvastatin 40mg + Clopidogrel Bisulphate IP Equivalent to Clopidogrel IP 75mg for M/s Pure And Cure Healthcare Pvt Limited.

It states that the price of each film uncoated bilayered tablets containing: Atorvastatin Calcium IP Equivalent to Atorvastatin 40mg + Clopidogrel Bisulphate IP Equivalent to Clopidogrel IP 75mg for M/s Pure And Cure Healthcare Pvt Limited has been revised to Rs. 25.61/-.

[Notification no. 19(4430)/2025/DP/NPPA/DIV.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT